Try our Advanced Search for more refined results

Vioxx Deal Holds Up Even After Appeals Wins: Experts

By Ron Zapata (May 30, 2008, 12:00 AM EDT) -- Merck & Co Inc. crafted its $4.85 billion Vioxx settlement despite winning 12 of 17 jury verdicts over the painkiller. Although appeals courts have recently overturned two of those verdicts, lowered damages in a third case and rejected medical monitoring claims in still another, many legal pundits agree with Merck that settling before the appellate rulings was ultimately the right decision....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!